Paul Keown

Title: Paul Keown: Innovator in Cardiac Transplantation Diagnostics

Introduction

Paul Keown is a notable inventor based in Delta, California. He has made significant contributions to the field of cardiac transplantation through his innovative research and patents. His work focuses on improving the diagnosis of acute rejection in heart transplant patients.

Latest Patents

Paul Keown holds a patent for "Biomarkers for the detection of acute rejection in heart transplantation." This patent outlines methods for diagnosing acute rejection of a cardiac allograft in a subject using genomic expression profiling, proteomic expression profiling, or both. The techniques involve panels of nucleic acid markers and proteomic markers, which enhance the accuracy of rejection diagnosis.

Career Highlights

Keown is affiliated with the University of British Columbia, where he continues to advance research in the field of transplantation. His work has been instrumental in developing diagnostic tools that can potentially save lives by allowing for timely interventions in transplant patients.

Collaborations

Throughout his career, Paul Keown has collaborated with esteemed colleagues such as Bruce McManus and Raymond Ng. These partnerships have fostered a collaborative environment that promotes innovation and research excellence.

Conclusion

Paul Keown's contributions to cardiac transplantation diagnostics exemplify the impact of innovative research in medicine. His patent and ongoing work at the University of British Columbia highlight the importance of advancements in this critical field.